Comparison of recurrence patterns between ≤5 years and >5 years after curative operations in colorectal cancer patients

J Surg Oncol. 2013 Jul;108(1):9-13. doi: 10.1002/jso.23349. Epub 2013 Jun 10.

Abstract

Background and objectives: To identify characteristics of recurrent colorectal cancer in terms of follow-up periods, that is, ≤5 years and >5 years after curative operations

Methods: This study enrolled 4,023 patients. Of them, 835 patients showed recurrence after primary curative resection for colorectal cancer. Recurrence occurred ≤5 years (n = 799) or >5 years (n = 36) after curative surgery. Variables and recurrence patterns were compared between the groups.

Results: Among the 835 patients who experienced recurrence, only 4.3% recurred >5 years after surgery. This group showed lower preoperative serum carcinoembryonic antigen levels, more tumors with expanding growth, well-differentiated histology, and no lymph node metastasis (all P < 0.05). In terms of haematogenous metastasis, lung or liver was the most prevalent site in patients who recurred after >5 years or ≤5 years, respectively (P = 0.005). In rectal cancer patients, recurrence patterns revealed the same results. In colon cancer patients, the liver was the most prevalent site in both groups.

Conclusions: After 5 years of follow-up, routine surveillance for detecting other malignancies seems to be sufficient. However, the possibility of late (particularly late pulmonary) recurrence should be considered. Radiologic examination to detect pulmonary metastasis should be considered in the follow-up program.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenocarcinoma / pathology
  • Adenocarcinoma / therapy
  • Biomarkers, Tumor / blood
  • Carcinoembryonic Antigen / blood
  • Chemotherapy, Adjuvant
  • Colonic Neoplasms / pathology*
  • Colonic Neoplasms / therapy
  • Female
  • Follow-Up Studies
  • Humans
  • Liver Neoplasms / secondary*
  • Lung Neoplasms / secondary*
  • Male
  • Middle Aged
  • Neoplasm Recurrence, Local / pathology*
  • Radiotherapy, Adjuvant
  • Rectal Neoplasms / pathology*
  • Rectal Neoplasms / therapy

Substances

  • Biomarkers, Tumor
  • Carcinoembryonic Antigen